Head to Head Comparison: Adherex Technologies (NASDAQ:FENC) and Aurora Cannabis (NASDAQ:ACB)

Aurora Cannabis (NASDAQ:ACB) and Adherex Technologies (NASDAQ:FENC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Aurora Cannabis and Adherex Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	2	2	1	0	1.80
Adherex Technologies	1	1	4	0	2.50

Adherex Technologies has a consensus price target of $17.00, suggesting a potential upside of 46.61%. Given Adherex Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe Adherex Technologies is more favorable than Aurora Cannabis.

Volatility & Risk

Aurora Cannabis has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, Adherex Technologies has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.

Insider & Institutional Ownership

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 55.5% of Adherex Technologies shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 10.7% of Adherex Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Aurora Cannabis and Adherex Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.70%	3.72%	3.03%
Adherex Technologies	-6.09%	-5.71%	-2.37%

Earnings and Valuation

This table compares Aurora Cannabis and Adherex Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$247.82 million	1.30	-$88.13 million	($0.98)	-4.99
Adherex Technologies	$44.64 million	9.15	-$9.74 million	($0.13)	-89.19

Adherex Technologies has lower revenue, but higher earnings than Aurora Cannabis. Adherex Technologies is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Summary

Adherex Technologies beats Aurora Cannabis on 10 of the 14 factors compared between the two stocks.

About Aurora Cannabis

Aurora Cannabis is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2006, it grows, processes and sells cannabis products, with a primary focus on medical cannabis and additional sales in Canada’s adult-use market. The company’s products include dried cannabis flower, oils and other cannabis-based formats. Aurora markets products under brands such as Aurora, MedReleaf and San Rafael ’71, and supplies medical cannabis to patients and customers in Canada and international markets, including parts of Europe and Australia.

About Adherex Technologies

Adherex Technologies was a biotechnology company focused on developing treatments for cancer. In 2014, the company changed its name to Fennec Pharmaceuticals Inc.; Fennec later adopted the Nasdaq ticker FENC. Fennec is a commercial-stage biopharmaceutical company focused on therapies that address complications of cancer treatment. Its principal product is PEDMARK, a sodium thiosulfate injection approved in the United States to reduce the risk of cisplatin-related hearing damage in certain pediatric patients with cancer.